Clinical Trial Update: Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

View source ↗

Summary

This clinical trial investigates tear and blood biomarkers to discover signatures associated with aggressive prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of Arkansas | Conditions: Prostate Cancer | Status: ACTIVE_NOT_RECRUITING